Product Name

  • Name

    maitansine

  • EINECS 252-754-7
  • CAS No. 35846-53-8
  • Article Data3
  • CAS DataBase
  • Density 1.32g/cm3
  • Solubility
  • Melting Point 183.5-184℃
  • Formula C34H46 Cl N3 O10
  • Boiling Point 895.1°Cat760mmHg
  • Molecular Weight 692.206
  • Flash Point 495.1°C
  • Transport Information
  • Appearance
  • Safety A deadly poison by intraperitoneal and intravenous routes. Moderately toxic by subcutaneous route. Human systemic effects by intravenous route: hallucinations, distorted perceptions, change in motor activity, and nausea or vomiting. An experimental teratogen. Mutation data reported. Used as an antineoplastic agent. When heated to decomposition it emits very toxic fumes of Cl and NOx.
  • Risk Codes
  • Molecular Structure Molecular Structure of 35846-53-8 (maitansine)
  • Hazard Symbols
  • Synonyms L-Alanine, N-acetyl-N-methyl-,11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-ylester, [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-;Maitansine;Maysanine;Maytansin;N-Acetyl-N-methyl-L-alanine [1S-(1R*,2S*,3R*,5R*,6R*,16E,18E,20S*,21R*)]-11-chloro-21-hydroxy-12,20-dimethoxy-2,5,9,16-tetramethyl-8,23-dioxo-4,24-dioxa-9,22-diazatetracyclo[19.3.1.110,14.03,5]hexacosa-10,12,14(26),16,18-pentaen-6-ylester;NSC 153858;
  • PSA 156.47000
  • LogP 3.92820

Synthetic route

maytansine 9-O-methyl ether
64817-73-8

maytansine 9-O-methyl ether

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
With pyridine hydrochloride In tetrahydrofuran at 25℃; for 14h;95%
4-deoxymaytansinol
75340-67-9

4-deoxymaytansinol

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
2: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
3: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
4: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
(3E,5E,14E)-(7R,8S,12S,13S,16S)-21-Chloro-16-hydroxy-7,8,22-trimethoxy-3,13,15,19-tetramethyl-11-oxa-9,19-diaza-tricyclo[18.3.1.18,12]pentacosa-1(24),3,5,14,20,22-hexaene-10,18-dione
75349-70-1

(3E,5E,14E)-(7R,8S,12S,13S,16S)-21-Chloro-16-hydroxy-7,8,22-trimethoxy-3,13,15,19-tetramethyl-11-oxa-9,19-diaza-tricyclo[18.3.1.18,12]pentacosa-1(24),3,5,14,20,22-hexaene-10,18-dione

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
2: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
3: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
C36H56ClNO5S2Si
75340-66-8

C36H56ClNO5S2Si

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 1.) pyridine, 2.) aq. ammonium hydroxide / 1.) 27 deg C, 20 min, 2.) tert-butyl alcohol, 27 deg C, 2 h
2: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
3: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
4: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
5: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
6: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
7: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
3-O-(tert-butyldimethylsilyl)-4,5-deoxymaytansinol
75349-69-8

3-O-(tert-butyldimethylsilyl)-4,5-deoxymaytansinol

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
2: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
3: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
4: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
5: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
C37H57ClN2O6S2Si
75349-68-7

C37H57ClN2O6S2Si

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
2: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
3: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
4: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
5: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
6: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
C40H64ClNO6S2Si

C40H64ClNO6S2Si

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 8 steps
1: 1.) 2-propanethiol, boron trifluoride etherate, 2.) silver nitrate, aq. 2,6-lutidine / 1.) methylene chloride, - 78 deg C, 5 min, 2.) THF, 25 deg C, 1.75 h
2: 1.) pyridine, 2.) aq. ammonium hydroxide / 1.) 27 deg C, 20 min, 2.) tert-butyl alcohol, 27 deg C, 2 h
3: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
4: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
5: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
6: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
7: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
8: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
(E)-(3S,6S,7S)-3-(tert-Butyl-dimethyl-silanyloxy)-8-{2-[(2E,4E)-(R)-6-(4-chloro-3-methoxy-5-methylamino-phenyl)-1-methoxy-5-methyl-hexa-2,4-dienyl]-[1,3]dithian-2-yl}-7-(2-methoxy-propoxy)-4,6-dimethyl-oct-4-enoatetetrabutyl-ammonium;

(E)-(3S,6S,7S)-3-(tert-Butyl-dimethyl-silanyloxy)-8-{2-[(2E,4E)-(R)-6-(4-chloro-3-methoxy-5-methylamino-phenyl)-1-methoxy-5-methyl-hexa-2,4-dienyl]-[1,3]dithian-2-yl}-7-(2-methoxy-propoxy)-4,6-dimethyl-oct-4-enoatetetrabutyl-ammonium;

maytansine
35846-53-8

maytansine

Conditions
ConditionsYield
Multi-step reaction with 9 steps
1: 71 percent / mesitylenesulfonyl chloride, diisopropylethylamine / benzene / 28 h / 40 °C
2: 1.) 2-propanethiol, boron trifluoride etherate, 2.) silver nitrate, aq. 2,6-lutidine / 1.) methylene chloride, - 78 deg C, 5 min, 2.) THF, 25 deg C, 1.75 h
3: 1.) pyridine, 2.) aq. ammonium hydroxide / 1.) 27 deg C, 20 min, 2.) tert-butyl alcohol, 27 deg C, 2 h
4: mercuric chloride, aq. calcium carbonate / acetonitrile / 12 h / 25 °C
5: 83 percent / aq. HF / acetonitrile / 0.75 h / 0 °C
6: 0.1 percent p-toluenesulfonic acid / 0.5 h / 25 °C
7: 87 percent / tert-butyl hydroperoxide, oxyvanadium(IV) bis(acetylacetonate), 2,6-lutidine / benzene; toluene / 3.5 h / 25 °C
8: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
9: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: imidazole / dimethylformamide; 1,2-dimethoxy-ethane / 75 h / 45 - 47 °C
2: 95 percent / aq. pyridinium chloride / tetrahydrofuran / 14 h / 25 °C
View Scheme
methanol
67-56-1

methanol

maytansine
35846-53-8

maytansine

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-15,7r,84-trimethoxy-3,9c,11t,15-tetramethyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione
64817-73-8

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-15,7r,84-trimethoxy-3,9c,11t,15-tetramethyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione

Conditions
ConditionsYield
With trifluoroacetic acid In benzene Ambient temperature;
1-thiopropane
107-03-9

1-thiopropane

maytansine
35846-53-8

maytansine

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-84-propylsulfanyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione
64817-76-1

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-84-propylsulfanyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione

Conditions
ConditionsYield
With trifluoroacetic acid In dichloromethane for 15h; Ambient temperature;
ethanol
64-17-5

ethanol

maytansine
35846-53-8

maytansine

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-84-ethoxy-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione
53092-34-5

(3E,5E,7R,84Ξ,86S)-12c-(N-acetyl-N-methyl-L-alanyloxy)-14-chloro-10t,11c-epoxy-84-ethoxy-15,7r-dimethoxy-3,9c,11t,15-tetramethyl-15-aza-1(1,3)-benzena-8(4,6)-[1,3]oxazinana-cyclopentadecaphane-3,5-diene-82,14-dione

Conditions
ConditionsYield
With trifluoroacetic acid In benzene Ambient temperature;
maytansine
35846-53-8

maytansine

4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)aniline
214360-73-3

4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)aniline

C40H52N4O10

C40H52N4O10

Conditions
ConditionsYield
With potassium phosphate; (2-dicyclohexylphosphino-2’,4’,6’-triisopropyl-1,1 ‘-biphenyl)[2-(2’-amino-1,1‘-biphenyl)]palladium(II) methanesulfonate In tetrahydrofuran; water at 20℃; for 17h; Inert atmosphere; Sealed tube;17.3 mg

Maytansine History

in 1972,Maytansine was first isolated  from the African plant, Maytenus ovatus (Celastraceae), later renamed Maytenus serrata,by Kupchan and co-workers in a yield of 0.2 mg/kg of dried plant material.

Maytansine Specification

Maytansine, with the CAS NO. 35846-53-8, is also called Maitansine; Maysanine; Maytansin. Maytansine is an ansamycin antibiotic originally isolated from the Ethiopian shrub Maytenus serrata. Maytansine binds to tubulin at the rhizoxin binding site, thereby inhibiting microtubule assembly, inducing microtubule disassembly, and disrupting mitosis.

Physical properties about Maytansine are: (1)ACD/LogP: 4.066; (2)# of Rule of 5 Violations: 2; (3)ACD/LogD (pH 5.5): 4.07; (4)ACD/LogD (pH 7.4): 4.07; (5)ACD/BCF (pH 5.5): 724.76; (6)ACD/BCF (pH 7.4): 722.57; (7)ACD/KOC (pH 5.5): 3880.82; (8)ACD/KOC (pH 7.4): 3869.11; (9)#H bond acceptors: 13; (10)#H bond donors: 2; (11)#Freely Rotating Bonds: 7; (12)Index of Refraction: 1.59 ; (13)Molar Refractivity: 176.691 cm3; (14)Molar Volume: 523.775 cm3; (15)Polarizability: 70.046 10-24cm3; (16)Surface Tension: 57.5769996643066 dyne/cm; (17)Density: 1.322 g/cm3; (18)Flash Point: 495.133 °C; (19)Enthalpy of Vaporization: 136.306 kJ/mol; (20)Boiling Point: 895.091 °C at 760 mmHg

You can still convert the following datas into molecular structure:
(1)InChI=1S/C34H46ClN3O10/c1-18-11-10-12-26(45-9)34(43)17-25(46-32(42)36-34)19(2)30-33(5,48-30)27(47-31(41)20(3)37(6)21(4)39)16-28(40)38(7)23-14-22(13-18)15-24(44-8)29(23)35/h10-12,14-15,19-20,25-27,30,43H,13,16-17H2,1-9H3,(H,36,42)/b12-10-,18-11+/t19-,20+,25+,26-,27-,30-,33+,34+/m1/s1;
(2)InChIKey=WKPWGQKGSOKKOO-AQPVFDFWSA-N;
(3)SmilesC[C@@H]1[C@@H]2C[C@]([C@@H](/C=C\C=C(\Cc3cc(c(c(c3)OC)Cl)N(C(=O)C[C@H]([C@]4([C@@H]1O4)C)OC(=O)[C@H](C)N(C)C(=O)C)C)/C)OC)(NC(=O)O2)O;

The toxicity data is as follows:

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
human TDLo intravenous 190ug/kg/5D (.19mg/kg) GASTROINTESTINAL: NAUSEA OR VOMITING

BEHAVIORAL: "HALLUCINATIONS, DISTORTED PERCEPTIONS"

BEHAVIORAL: CHANGES IN MOTOR ACTIVITY (SPECIFIC ASSAY)
Journal of the National Cancer Institute. Vol. 60, Pg. 93, 1978.
mouse LD50 intraperitoneal 245ug/kg (.245mg/kg)   National Cancer Institute Screening Program Data Summary, Developmental Therapeutics Program. Vol. JAN1986,
mouse LD50 intravenous 1530ug/kg (1.53mg/kg) BLOOD: THROMBOCYTOPENIA

BLOOD: LEUKOPENIA

SKIN AND APPENDAGES (SKIN): HAIR: OTHER
National Technical Information Service. Vol. PB82-165507,
rat LD50 subcutaneous 480ug/kg (.48mg/kg)   Cancer Treatment Reports. Vol. 61, Pg. 1333, 1977.
rat LD50 subcutaneous 480ug/kg (.48mg/kg) LUNGS, THORAX, OR RESPIRATION: DYSPNEA

GASTROINTESTINAL: "HYPERMOTILITY, DIARRHEA"
Cancer Treatment Reports. Vol. 61, Pg. 1333, 1977.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View